晚孕期第三次超声扫描正常的胎儿死亡与严重疾病的风险因素:基于人群的队列研究
该回顾性人群队列研究纳入40 169例孕35+1至36+6周超声无小于胎龄儿(SGA)或胎儿生长受限(FGR)证据的单胎妊娠,死胎率0.1%,严重复合不良结局0.6%,严重SGA 0.7%。子痫前期与死胎相关(OR 4.46),严重复合不良结局仅与孕前糖尿病(aOR 2.82)和初产(aOR 1.56)相关。作者认为对无SGA/FGR证据的胎儿,预测死亡和严重疾病的能力差,超声进一步减少足月不良结局的作用有限。
要点
- 晚孕期超声无SGA/FGR证据的胎儿中,死胎率0.1%,严重复合不良结局0.6%。
- 子痫前期与死胎相关(OR 4.46),对死胎的人群归因分数为9.6%。
- 严重复合不良结局仅与孕前糖尿病(aOR 2.82)和初产(aOR 1.56)相关。
核心结论
- 对超声无SGA和FGR证据的胎儿,预测死亡和严重疾病的能力差。
- 在这些胎儿中,超声进一步减少足月不良结局的作用有限。
研究设计与样本
- 回顾性基于人群的队列研究,纳入英国一家大型产科单位7年间孕35+1至36+6周接受普遍超声扫描的单胎、非畸形足月妊娠。
- 排除合并SGA或FGR的妊娠,研究人群为40 169例妊娠,占所有合格足月妊娠的88.9%。
- 采用单变量和多变量逻辑回归分析评估潜在临床、人口学和超声风险因素。
主要发现
- 死胎48例(0.1%),严重复合不良结局221例(0.6%),严重SGA(出生体重<第3百分位)295例(0.7%)。
- 5例(10.4%)死胎分娩时体重<第10百分位(aOR 2.70,95%CI 1.06-6.92);23例(47.9%)死胎被认为原因不明。
- 子痫前期与死胎相关(OR 4.46,95%CI 1.99-9.96),其他产前因素包括超声胎儿生长测量均未显示与死胎显著相关。
- 子痫前期对死胎的人群归因分数为9.6%。
- 严重复合不良结局仅与孕前糖尿病(aOR 2.82,95%CI 1.02-7.85)和初产(aOR 1.56,95%CI 1.19-2.04)相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify antepartum risk factors for fetal or neonatal mortality and severe morbidity in pregnancies undergoing a universal late third-trimester ultrasound scan in which there was no ultrasound evidence of small-for-gestational age (SGA) or fetal growth restriction (FGR). METHODS: This was a retrospective population-based cohort study of singleton, non-anomalous term pregnancies undergoing a universal ultrasound scan at 35 + 1 to 36 + 6 weeks' gestation at a major UK maternity unit, over a period of 7 years. Pregnancies complicated by SGA or FGR were excluded. The outcomes were: stillbirth; severe composite adverse outcome, including extended perinatal mortality and severe morbidity; and severe SGA, defined as birth weight < 3rd centile. Potential clinical, demographic and ultrasonographic risk factors were evaluated using univariate and multivariate logistic regression analysis. RESULTS: The study population of 40 169 pregnancies comprised 88.9% of all eligible term pregnancies. There were 48 (0.1%) stillbirths, 221 (0.6%) cases of severe composite adverse outcome and 295 (0.7%) cases of severe SGA. Five (10.4%) stillborn infants weighed < 10th centile at delivery (adjusted odds ratio (aOR), 2.70 (95% CI, 1.06-6.92)); 23 (47.9%) cases of stillbirth were considered unexplained. Pre-eclampsia was associated with stillbirth (odds ratio, 4.46 (95% CI, 1.99-9.96)) but no other antenatal factors, including ultrasound measures of fetal growth, showed a significant association with this outcome. Pre-eclampsia constituted 9.6% of the population-attributable fraction for stillbirth. Severe composite adverse outcome was associated only with pre-existing diabetes (aOR, 2.82 (95% CI, 1.02-7.85)) and nulliparity (aOR, 1.56 (95% CI, 1.19-2.04)). CONCLUSIONS: The potential to predict mortality and severe morbidity in fetuses without ultrasound evidence of SGA and FGR is poor. In these fetuses, the role of ultrasound in further reducing adverse outcomes at term is limited. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- D'Alberti E, Dockree S, Garbagnati M, et al. Risk factors for mortality and severe morbidity in fetuses with normal late third-trimester scan: population-based cohort study. Ultrasound Obstet Gynecol. 2025. PMID: 40519155. doi:10.1002/uog.29256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。